Agyeman, Abena S.
Jun, Wesley J.
Proia, David A.
Kim, Caroline R.
Skor, Maxwell N.
Kocherginsky, Masha
Conzen, Suzanne D.
Funding for this research was provided by:
National Institutes of Health (P50CA125183, P30CA014599)
Susan G. Komen for the Cure (PDF15333330)
Article History
Received: 5 October 2015
Accepted: 5 January 2016
First Online: 8 February 2016
Compliance with Ethical Standards
:
: D. A. Proia is the Director of Cancer Biology at Synta Pharmaceuticals Corp.
Free to read: This content has been made available to all.